WHO ICTRP trial

The add-on effect of Tiotropium bromide to ICS/LABA combination inhaler for the…

JPRN-UMIN000019964 · Japan Primary Registries Network (JPRN) · Not Recruiting

Key facts

Trial ID JPRN-UMIN000019964
Public title The add-on effect of Tiotropium bromide to ICS/LABA combination inhaler for the patients with severe uncontrolled asthma
Scientific title The add-on effect of Tiotropium bromide to ICS/LABA combination inhaler for the patients with severe uncontrolled asthma - Add-on effect of TIO for severe asthmatics
Primary sponsor National Center for Global Health and Medicine
Registry Japan Primary Registries Network (JPRN)
Recruitment status Not Recruiting
Study type Interventional
Phase Not applicable
Countries Japan
Conditions bronchial asthma
Interventions Tiotropium bromide once daily two puffs 6 months treatment
Registration date Nov 28, 2015
Target size 50
Registry page center6.umin.ac.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations